A large independent orthopaedic group in Grand Rapids whose main Leffingwell campus offers platelet injections and, case by case, bone marrow stem cell injections.
Orthopaedic Associates of Michigan is a large independent orthopaedic group practice serving the Grand Rapids area, and this entry covers its main site, the Leffingwell campus at 1111 Leffingwell Avenue NE, telephone (616) 459-3900, open 8am to 5pm Monday to Friday. It is not a stem cell clinic: it is a full orthopaedic practice with subspecialty teams in spine, foot and ankle, hand and upper limb, sports medicine, joint reconstruction, trauma and physical medicine and rehabilitation, plus an urgent orthopaedic care service, physiotherapy and occupational rehabilitation, a bone health clinic, on-site radiology, custom orthotics and its own surgery centre at MidTowne. Regenerative injections are one small part of that.
The practice has a dedicated regenerative medicine page, and it is unusually plain-spoken. Two treatments are described. Platelet rich plasma (PRP) is prepared from a normal blood draw: the blood is spun in a centrifuge and the concentrated platelet portion, which contains growth factors, is separated out and injected. Mesenchymal stem cell injection uses bone marrow taken from the back of the patient's own pelvis under local anaesthetic and sterile conditions, which is then centrifuged to concentrate the cell layer. Both are therefore autologous, meaning the material comes from the patient's own body, and the practice names no donor, amniotic or umbilical product.
Two things on that page are worth a prospective patient's attention. First, the practice says it currently offers platelet treatment and assesses each case individually for suitability for stem cell injection, so the cell treatment is not presented as routinely available. Second, it states directly that these treatments are still considered investigational and are not covered by commercial insurance — a franker statement than most clinics make. It says platelet treatment has clinical evidence behind it for tendon and muscle injuries, osteoarthritis and discogenic back pain, and that the stem cell work is less well studied but with more clinical studies appearing each year. No success rates are claimed.
Two clinicians are named as providing these treatments, Dr James Lee and Dr Adam Hull. The wider group lists many other surgeons across its subspecialties. For everything except the cost of the regenerative injections, this practice works like a conventional orthopaedic provider: referrals, insurance billing, imaging and surgery through its own facilities. The site does not state a founding year, though it describes itself as West Michigan's most established orthopaedic practice, and it does not list languages spoken or accreditation details.
The group covers general orthopaedics; the conditions below are those the site names in connection with its regenerative injections, alongside its broader specialty areas.
The site says its stem cell injections use mesenchymal cells concentrated from bone marrow taken from the back of the patient's own pelvis, and its platelet injections come from an ordinary blood draw.
The site names two clinicians as providing the regenerative injections; the wider group includes many other orthopaedic surgeons across its subspecialties.
The Leffingwell campus at 1111 Leffingwell Avenue NE in Grand Rapids is the group's main office, open 8am to 5pm Monday to Friday, and the site lists physiotherapy, hand therapy, work conditioning, a bone health clinic, custom orthotics and radiology on site. The group has several other sites in the area: a newer south-west office in Wyoming with a walk-in injury clinic, an urgent orthopaedic care centre on Leonard Street, separate physical rehabilitation offices in Wyoming and south-east Grand Rapids, a Greenville office, and its own MidTowne surgery centre. This is a substantially larger operation than most providers in this directory, with imaging and surgical facilities under the same organisation.
The site publishes no prices, but it is clearer than most about coverage: it states that the platelet and stem cell treatments are still considered investigational and are not covered by commercial insurance, meaning a patient would pay for them privately even though much of the group's other orthopaedic work is billed to insurance. The actual figures would have to be obtained from the practice.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.